Compositions and methods for enhanced transepithelial and transe

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Cosmetic – antiperspirant – dentifrice

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424447, 4352401, 4352402, 4352403, 43524031, C12N 502, C12N 506, C12N 508

Patent

active

052543420

DESCRIPTION:

BRIEF SUMMARY
m comprising: (1) a carrier molecule selected from the group consisting of transferrin receptor ligands to which an active agent of interest may be conjugated; and (2) a transport enhancing agent (e.g., monensin or BFA) which enhances transendothelial or transepithelial transport of the transferrin receptor ligand/active agent conjugate via the TfR's.


BRIEF DESCRIPTION OF THE DRAWINGS

The invention may be better understood with reference to the accompanying drawings, in which:
FIGS. 1A and 1B illustrate the levels of transcytosis of .sup.125 I-Tf and HRP achieved in filter-grown MDCK cells, respectively;
FIGS. 2A and 2B illustrate the results of pulse-chase experiments monitoring processing of cell-associated .sup.125 I-Tf with and without addition of bufeldin A (BFA), respectively;
FIG. 3 illustrates changes in the specific binding of .sup.125 I-Tf to the basal and apical membranes upon treatment with BFA;
FIGS. 4A-4C illustrate the results of experiments to determine the effects of BFA on TfR-mediated uptake of .sup.59 Fe, FIG. 4A showing uptake from the apical membrane, 4B uptake from the basolateral membrane and 4C transcytosis in the basal-to-apical direction;
FIGS. 5A and 5B illustrate the results of experiments to determine the effects of monensin and NH.sub.4 Cl on the transcytosis of HRP-SS-Tf (FIG. 5A) and HRP (FIG. 5B);
FIGS. 6A and 6B illustrate the results of experiments to determine the effects of BFA on the transcytosis of HRP-SS-Tf and HRP, respectively; and
FIG. 7 illustrates the elution pattern of transcytosed TF-SS-HRP and a control standard in Sephacryl S-200 gel chromatography.


DETAILED DESCRIPTION OF THE INVENTION

The present invention involves the use of non-specific and specific-membrane binding ligands as well as the use of agents which can perturb intracellular protein sorting processes to significantly increase the transport of a macromolecular protein across the cells via endocytotic and transcytotic mechanisms.
During the last decade, most of the studies on drug transepithelial transport have been carried out at tissue and organ levels. For example, various types of intestinal samples, such as everted intestine preparations, intestinal ring slices and mucosal sheets have been used. Because of such factors as cellular heterogeneity, complexity in geometric structure, inaccessibility of the serosal side of the epithelium, and limited viability of epithelial cells in the isolated tissues, it is very difficult to use these methods for specific mechanistic studies on transepithelial transport of the drugs.
Purified brush border membrane vesicles, basolateral membrane vesicles and isolated intestinal epithelial cells have also been used to study drug transport. Although membrane vesicles offer an excellent model to study transport properties of solutes without the interference of cellular metabolism, they may not be suitable for studies on the endocytosis and transcytosis of macromolecules because of lack of membrane internalization. In addition, results from these membrane vesicles may not correlate well with those from viable cells. Isolated intestinal epithelial cell is a very good model to study the cellular binding, uptake and transport of drugs, but it suffers from short viability; therefore, the practical use of this type of cell is limited.
Cultured filter-grown epithelial cells, on the other hand, show many advantages as a model system. For example, the viability of the cell can be maintained for almost as long as it is needed, and studies on the interaction between peptides/proteins and cells can be carried out readily without the potential interference from other mucosal structures which are normally found in tissue samples. In addition, filter-grown epithelial cells allow easy access to both apical and basal side of the cell. The experimental data obtained is generally more reliable and easy to interpret, because of the relative homogeneity of the cell population. Other desirable properties, such as high sensitivity, reproducibility, and small sample requirements, a

REFERENCES:
patent: 5108921 (1992-04-01), Lowe et al.
Artursson, P., "Epithelial Transport of Drugs in Cell Culture", J. Pharm. Sci. 79:476-482 (1990).
Balch, W. E., "Biochemistry of Interorganelle Transport", J. Biol. Chem. 264:16956-16968 (1989).
Banerjee, D. Flanagan et al., "Transferrin Receptors in the Human Gastrointestinal Tract: Relationship to Body Iron Stores", Gastroenterology 91:861-869 (1986).
Breitfeld, P. P. et al., "Sorting Signals, Current Opinion", Cell Biol. 1:617-623 (1989).
Chantret, I. et al., "Epithelial Polarity, Villin Expression, and Enterocytic Differentiation of Cultured Human Colon Carcinoma Cells: A survey of Twenty Cell Lines", Cancer Research48:1936-1942 (1988).
Cho, M. J. et al., "The Madin Carby Canine Kidney (MDCK) Epithelial Cell Monolayer as a Model Cellular Transport Barrier", Pharm. Research. 6, No. 1.
Dautry-varsat, A. et al., "pH and the Recycling of Transferring During Receptor Mediated Endocytosis", Proc. Natl. Acad. Sci. USA 80:2258-2262 (1983).
Davis, C. G. et al., "The Low Density Lipoprotein Receptor", J. Biol. Chem. 262:4075 (1987).
DeDuve, C., "Lysosomes Revisited", Eur. J. Biochem., 137:391-397 (1983).
Farquhar, M. G., "Recovery of Surface Membrane in Anterior Pituitary Cells. Variations in Traffic Detected with Anionic and Cationic Ferritin", J. Cell Biol. 77:/R35-42 (1978).
Farquhar, M. G. "Membrane Recycling in Secretory Cells: Implications For Traffic of Products and Specialized Membranes Within the Golgi Complex", Cell. Biol. 23:399-427 (1981).
Fishman, J. B. et al., "Receptor-Mediated Transcytosis of Transferring Across the Blood Brain Barrier", J. Neuroscience Res. 18:299-304 (1987).
Fishman, J. B. and Fine, R. E., "A Trans Golgi-Derived Exocytic Coated Vesicle Can Contain Both Newly Synthesized Cholinesterase and Inernalized Transferrin", Cell 48:157-164 (1987).
Friden, P. M. et al., "Anti-transferrin Receptor Antibody and Antibody-drug Conjugates Cross the Blood-brain Barrier", Proc. Natl. Acad. Sci USA 88:4771-4775 (1991).
Fujiwara, T. et al., "Brefeldin A Causes Disassembly of the Golgi Complex and Accumulation of Secretory Protein in the Endoplasmic Reticulum", J. Biol. Chem. 263:18545-18552.
Fuller, S. D., and Simons, K., "Transferrin Receptor Polarity and Recycling Accuracy in Tight and Leaky Strains of Madin-Darby Canine Kidney Cells", J. Cell. Biol. 103:1767-1779 (1986).
Ghitescu, L. et al., "Specific Binding Sites for Albumin Restricted to Plasmalemmal Vesicles of Continuous Capillary Endothelium: Receptor-mediated Transcytosis", J. Cell. Biol. 102:1304-1311 (1986).
Glenney, J. R. et al., Cell 52:675 (1988).
Goldberg, D. E. and Kornfeld, S., "Evidence for Extensive Subcellular Organization of Asparagine-linked Oligasaccharide Processing and Lysosomal Enzyme Phosphorylation", J. Biol. Chem. 258:3159-3165 (1983).
Gonzalez-Mariscal, L., "Tight Junction Formation in Cultured Epithelial Cells (MDCK)", J. Membr. Biol. 86:113-125 (1985).
Grasset, E. et al., "Epithelial Properties of Human Colonic Carcinoma Cell Line Caco-2: Electrical Parameters", Am. J. Physiol. 247:C2560-C267 (1984).
Herzog, V. and Farquhar, M. G., "Luminal Membrane Retrieved After Exocytosis Reaches Most Golgi Chisternea in Secretory Cells", Proc. Natl. Acad. Sci. USA 74:5073-5077 (1977).
Heyman, M. et al., "Quantification of Protein Transcytosis in the Human Colon Carcinoma Cell Line CaCo-2", J. Cell Physiol. 143:391-395 (1990).
Hidalgo, I. J. et al., "Characterization of the Human Colon Carcinoma Cell Line (Caco-2) As a Model System for Intestinal Epithelial Permeability", Gastroenterology 96:736-749 (1989).
Jeffries, A. E. et al., "Transferrin Receptor of Endothelium of Brain Capillaries", Nature 312:162-163 (1984).
Kato, S. et al., "Effects of Brefeldin A on the Synthesis and Secretion of Egg White Proteins in Primary Cultured Oviduct Cells of Laying Japanese Quail", Biochem. Biophy. Acta 991:36-43 (1989).
King, G. L. and Johnson, S. M., "Receptor-Mediated Transport of Insulin Across Endothelial Cells", Science 227:1583-158

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Compositions and methods for enhanced transepithelial and transe does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for enhanced transepithelial and transe, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for enhanced transepithelial and transe will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1349999

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.